Jason Merker

Assistant Professor of Pathology at the Stanford University Medical Center

Professional Education

Board Certification: Molecular Genetic Pathology, American Board of Pathology

Board Certification: Clinical Cytogenetics, American Board of Medical Genetics

Fellowship: Stanford Hospital and Clinics (06/2010) CA

Fellowship: Stanford Hospital and Clinics (06/2008) CA

Residency: Stanford Hospital and Clinics (08/2009) CA

Internship: Stanford Hospital and Clinics (08/2006) CA

Medical Education: University of North Carolina School of Medicine (08/2005) NC

Board Certification: Clinical Pathology, American Board of Pathology (2009)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Clinical interpretation and implications of whole-genome sequencing.
Dewey, F. E., Grove, M. E., Pan, C., Goldstein, B. A., Bernstein, J. A., & Quertermous, T. (2014). Clinical interpretation and implications of whole-genome sequencing. JAMA-the journal of the American Medical Association, 311(10), 1035-1045.

Clinical Interpretation and Implications of Whole-Genome Sequencing
Dewey, F. E., Grove, M. E., Pan, C., Goldstein, B. A., Bernstein, J. A., & Quertermous, T. (2014). Clinical Interpretation and Implications of Whole-Genome Sequencing. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 311(10), 1035-1044.

Comprehensive whole-genome sequencing of an early-stage primary myelofibrosis patient defines low mutational burden and non-recurrent candidate genes.
Merker, J. D., Roskin, K. M., Ng, D., Pan, C., Fisk, D. G., & Gotlib, J. (2013). Comprehensive whole-genome sequencing of an early-stage primary myelofibrosis patient defines low mutational burden and non-recurrent candidate genes. Haematologica, 98(11), 1689-1696.

STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia.
Ohgami, R. S., Ma, L., Merker, J. D., Martinez, B., Zehnder, J. L., & Arber, D. A. (2013). STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia. Leukemia, 27(11), 2244-2247.

Comprehensive whole-genome sequencing of an early-stage primary myelofibrosis patient defines low mutational burden and non-recurrent candidate genes.
Merker, J. D., Roskin, K. M., Ng, D., Pan, C., Fisk, D. G., & Gotlib, J. (2013). Comprehensive whole-genome sequencing of an early-stage primary myelofibrosis patient defines low mutational burden and non-recurrent candidate genes. Haematologica, 98(11), 1689-1696.

Feasibility of using microbeads with holographic barcodes to track DNA specimens in the clinical molecular laboratory.
Merker, J. D., O'Grady, N., Gojenola, L., Dao, M., Lenta, R., & Schrijver, I. (2013). Feasibility of using microbeads with holographic barcodes to track DNA specimens in the clinical molecular laboratory. PeerJ, 1.

Next-generation sequencing in hematologic malignancies: what will be the dividends?
Merker, J. D., Valouev, A., & Gotlib, J. (2012). Next-generation sequencing in hematologic malignancies: what will be the dividends?. Therapeutic advances in hematology, 3(6), 333-339.

Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
Oh, S. T., Simonds, E. F., Jones, C., Hale, M. B., Goltsev, Y., & Gotlib, J. (2010). Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms. BLOOD, 116(6), 988-992.

Individual Variation in the Germline Ig Gene Repertoire Inferred from Variable Region Gene Rearrangements
Boyd, S. D., Gaeta, B. A., Jackson, K. J., Fire, A. Z., Marshall, E. L., & Collins, A. M. (2010). Individual Variation in the Germline Ig Gene Repertoire Inferred from Variable Region Gene Rearrangements. JOURNAL OF IMMUNOLOGY, 184(12), 6986-6992.

Design and Evaluation of a Real-Time PCR Assay for Quantification of JAK2 V617F and Wild-Type JAK2 Transcript Levels in the Clinical Laboratory
Merker, J. D., Jones, C. D., Oh, S. T., Schrijver, I., Gotlib, J., & Zehnder, J. L. (2010). Design and Evaluation of a Real-Time PCR Assay for Quantification of JAK2 V617F and Wild-Type JAK2 Transcript Levels in the Clinical Laboratory. JOURNAL OF MOLECULAR DIAGNOSTICS, 12(1), 58-64.

Measurement and Clinical Monitoring of Human Lymphocyte Clonality by Massively Parallel V-D-J Pyrosequencing
Boyd, S. D., Marshall, E. L., Merker, J. D., Maniar, J. M., Zhang, L. N., & Fire, A. Z. (2009). Measurement and Clinical Monitoring of Human Lymphocyte Clonality by Massively Parallel V-D-J Pyrosequencing. SCIENCE TRANSLATIONAL MEDICINE, 1(12).

Growth of Histoplasma capsulatum isolates is better on potato dextrose agar with chloramphenicol than on brain heart infusion agar
Burtelow, M. A., Merker, J. D., & Baron, E. J. (2009). Growth of Histoplasma capsulatum isolates is better on potato dextrose agar with chloramphenicol than on brain heart infusion agar. JOURNAL DE MYCOLOGIE MEDICALE, 19(3), 197-199.

Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system
Weinberg, O. K., Seetharam, M., Ren, L., Seo, K., Ma, L., & Arber, D. A. (2009). Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system. BLOOD, 113(9), 1906-1908.

Cold agglutinin syndrome in pediatric liver transplant recipients
Wong, W., Merker, J. D., Nguyen, C., Berquist, W., Jeng, M., & Fontaine, M. J. (2007). Cold agglutinin syndrome in pediatric liver transplant recipients. PEDIATRIC TRANSPLANTATION, 11(8), 931-936.

Molecular diagnostics of non-Hodgkin lymphoma.
Merker, J. D., & Arber, D. A. (2007). Molecular diagnostics of non-Hodgkin lymphoma. Expert opinion on medical diagnostics, 1(1), 47-63.

Diagnosis of a critical respiratory illness caused by human metapneumovirus by use of a pan-virus microarray
Chiu, C. Y., Alizadeh, A. A., Rouskin, S., Merker, J. D., Yeh, E., & DeRisi, J. L. (2007). Diagnosis of a critical respiratory illness caused by human metapneumovirus by use of a pan-virus microarray. JOURNAL OF CLINICAL MICROBIOLOGY, 45(7), 2340-2343.

Microarray detection of human parainfluenzavirus 4 infection associated with respiratory failure in an immunocompetent adult
Chiu, C. Y., Rouskin, S., Koshy, A., Urisman, A., Fischer, K., & DeRisi, J. L. (2006). Microarray detection of human parainfluenzavirus 4 infection associated with respiratory failure in an immunocompetent adult. CLINICAL INFECTIOUS DISEASES, 43(8), E71-E76.